Retrospective analysis of Steven Johnson syndrome and toxic epidermal necrolysis over a period of 5 years from northern Karnataka, India

Indian Journal of Pharmacology

Volumn 45, Issue 1, 2013, Pages 80-82

  Naveen, Kikkeri Narayanasetty ^a   Pai, Varadraj V ^a   Rai, Vijetha ^a   Athanikar, Sharatchandra B ^a  

^a SDM COLLEGE OF MEDICAL SCIENCES AND HOSPITAL   (India)

Author keywords

Anti epileptics; ofloxacin; Stevens Johnson syndrome; toxic epidermal necrosis

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; CARBAMAZEPINE; CEFTRIAXONE; COTRIMOXAZOLE; IMMUNOGLOBULIN; LAMIVUDINE; LEVOFLOXACIN; OFLOXACIN; OLANZAPINE; PHENOBARBITAL; PHENYTOIN; RISPERIDONE; STEROID; VALPROIC ACID; ZIDOVUDINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; INDIA; MALE; NURSING CARE; RETROSPECTIVE STUDY; STEVENS JOHNSON SYNDROME; SUPPORT GROUP; TOXIC EPIDERMAL NECROLYSIS; TREATMENT RESPONSE;

ANTI-EPILEPTICS; OFLOXACIN; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; INDIA; INFANT; MALE; MIDDLE AGED; OFLOXACIN; RETROSPECTIVE STUDIES; STEVENS-JOHNSON SYNDROME; YOUNG ADULT;

EID: 84874821003     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.106441     Document Type: Article

References (22)

1. Sharma VK, Sethuraman G, Minz A. Stevens Johnson syndrome, toxic epidermal necrolysis and SJS-TEN overlap: A retrospective study of causative drugs and clinical outcome. Indian J Dermatol Venereol Leprol 2008;74:238-40.
2. Sharma VK, Sethuraman G. Adverse cutaneous reactions to drugs: An overview. J Postgrad Med 1996;42:15-22.
3. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classifi cation of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993;129:92-6.
4. Lyell A. Toxic epidermal necrolysis: An eruption resembling scalding of the skin. Br J Dermatol 1956;68:355-61.
5. Roujeau JC. The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: A clinical classifi cation. J Invest Dermatol 1994;102:28S-30.
6. Li LF, Ma C. Epidemiological study of severe cutaneous adverse drug reactions in a city district in China. Clin Exp Dermatol 2006;31:642-7.
7. Borchers AT, Lee JL, Naguwa SM, Cheema GS, Gershwin ME. Stevens-Johnson syndrome and toxic epidermal necrolysis. Autoimmun Rev 2008;7:598-605.
8. Khambaty MM, Hsu SS. Dermatology of the patient with HIV. Emerg Med Clin North Am 2010;28:355-68.
9. Garcia-Doval I, LeCleach L, Bocquet H, Otero XL, Roujeau JC. Toxic epidermal necrolysis and Stevens-Johnson syndrome: Does early withdrawal of causative drugs decreasethe risk of death Arch Dermatol 2000;136:323-7.
10. Schopf E, Stuhmer A, Rzany B, Victor N, Zentgraf R, Kapp JF. Toxic epidermal necrolysis and Stevens-Johnson syndrome: An epidemiologic study from West Germany. Arch Dermatol 1991;127:839-42.
11. Devi K, George S, Criton S, Suja V, Sridevi PK. Carbamazepine-the commonest cause of toxic epidermal necrolysis and Stevens-Johnson syndrome: A study of 7 years. Indian J Dermatol Venereol Leprol 2005;71:325-8.
12. Barvaliya M, Sanmukhani J, Patel T, Paliwal N, Shah H, Tripathi C. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJSTEN overlap: A multicentric retrospective study. J Postgrad Med 2011;57:115-9.
13. Roujeau JC, Guillaume JC, Fabre JP, Penso DP, Fletchet ML, Girre JP. Toxic epidermal necrolysis(Lyells syndrome). Arch Dermatol 1990;126:37-42.
14. Yamane Y, Aihara M, Ikezawa Z. Analysis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Japan from 2000 to 2006 Allergol Int 2007;56: 419-25.
15. Sharma VK, Sethuraman G, Kumar B. Cutaneous adverse drug reactions: Clinical pattern and causative agents-a 6 year series from Chandigarh, India. J Postgrad Med 2001;47:95-9.
16. Kamaliah MD, Zaimal D, Mokhtar N, Nazmi N. Erythema multiforme, Steven Johnson Syndrome, Toxic Epidermal Necrolysis in North East Malaysia. Int J Dermatol 1998;37:520-3.
17. Naveen KN, Arunkumar JS, Hanumanthayya K, Pai VV. Stevens-Johnson syndrome induced by sodium valproate monotherapy. Int J Crit Illn Inj Sci 2012;2:44-5.
18. Alanko K, Stubb S, Kaupinen K. Cutaneous drug reactions. Clinical types and causative agents. Acts Derm Venerol 1989;69:223-6.
19. Kauppinen K, Stubb S. Drug reactions. Causative agents and Clinical types. Acts Derm Venerol 1984;64:320-4.
20. Wong KC, Kennedy JP, Lee S. Clinical manifestations and outcome in 17 patients of Steven Johnson Syndrome and Toxic Epidermal Necrolysis. Australas J Dermatol 1999;40:131-4.
21. Fagot JP, Mockenhaupt M, Bouwes-Bavinck JN, Naldi L, Viboud C, Roujeau JC. Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. AIDS 2001;15:1843-8.
22. Kardaun SH, Jonkman MF. Dexamethasone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis. Acta Derm Venereol 2007;87:144-8.